Edwards Lifesciences Q4 Profit Declines; Issues Q1 Outlook - Quick Facts

(RTTNews) - Edwards Lifesciences Corp. (EW) posted fourth-quarter net income of $75.8 million, or $0.68 per share, compared to $91.1 million, or $0.77 per share, in the comparable quarter last year.

Adjusted net income for the latest fourth quarter was $101.5 million or $0.91 per share, compared to $106.5 million, or $0.90 per share in the year-ago period. On average, 21 analysts polled by Thomson Reuters expected earnings per share of $0.82 for the quarter. Analysts' estimates typically exclude one-time items.

Quarterly net sales advanced by 5.0 percent to $536.0 million, from $510.5 million. Analysts estimated revenues of $533.14 million for the quarter.

For the first quarter 2013, the company expects earnings per share before items to be between $0.61 and $0.75 and total sales in the range of $500 million - $550 million. Analysts project first-quarter earnings per share of $0.71 on $525.58 million in revenue.

For 2014, the company said it continues to expect earnings per share before items to be a wide range around $3.00 and total sales of $2.05 billion to $2.25 billion. Analysts project earnings of $3.07 per share and revenue of $2.16 billion in 2014.